p16 mutation spectrum in the premalignant condition Barrett's esophagus.
Mutation, promoter hypermethylation and loss of heterozygosity involving the tumor suppressor gene p16 (CDKN2a/INK4a) have been detected in a wide variety of human cancers, but much less is known concerning the frequency and spectrum of p16 mutations in premalignant conditions.We have determined the...
Main Authors: | Thomas G Paulson, Patricia C Galipeau, Lianjun Xu, Heather D Kissel, Xiaohong Li, Patricia L Blount, Carissa A Sanchez, Robert D Odze, Brian J Reid |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2585012?pdf=render |
Similar Items
-
High Goblet Cell Count Is Inversely Associated with Ploidy Abnormalities and Risk of Adenocarcinoma in Barrett's Esophagus.
by: Amitabh Srivastava, et al.
Published: (2015-01-01) -
Barrett's esophagus as a premalignant condition; medical and surgical therapeutic management
by: Vlad Denis Constantin, et al.
Published: (2023-10-01) -
Barrett's esophagus.
by: Bird-Lieberman, E, et al.
Published: (2008) -
Barrett’s Esophagus
by: CN Williams
Published: (1994-01-01) -
Barrett's Esophagus
by: Yong Kang Lee
Published: (2022-09-01)